Caricamento...
Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
PURPOSE: To elucidate the use of Ripasudil in patients of advanced glaucoma on maximally tolerated medical therapy who could not be offered the option of surgery due to the global pandemic lockdown. MATERIALS AND METHODS: Only patients with primary open angle glaucoma (POAG), who had a cup-disc rati...
Salvato in:
| Pubblicato in: | Clin Ophthalmol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238538/ https://ncbi.nlm.nih.gov/pubmed/34194222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S318897 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|